Pharmaniaga Berhad operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaniaga Berhad with three other
drug stores in Asia:
Henan Topfond Pharmaceutical, Ltd.
sales of 3.23 billion Chinese Renmimbi [US$529.61 million]
of which 52%
was Drug Wholesale),
Iwaki & Co., Ltd.
(51.95 billion Japanese Yen [US$506.55 million]
of which 32%
was Pharmaceutical Products), and
JW Holdings Corporation
based in South Korea
(511.95 billion Korean Won [US$482.25 million]
of which 85%
During the year ended December of 2012, sales at
Pharmaniaga Berhad were 1.81 billion Malaysian Ringgits (US$563.19 million).
increase of 19.2%
versus 2011, when the company's sales were 1.52 billion Malaysian Ringgits.
This was the third consecutive year of growth at Pharmaniaga Berhad.